Picture of Lakefront Biotherapeutics NV logo

LKFT Lakefront Biotherapeutics NV News Story

0.000.00%
nl flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Galapagos Says FY Outlook Reaffirmed, Total Net Revenues For HY 140.3 Mln Euros

Aug 1 (Reuters) - Galapagos NV  GLPG.AS :
    * GALAPAGOS NV: 2024 OUTLOOK REAFFIRMED:
    * GALAPAGOS NV: TOTAL NET REVENUES FOR SIX MONTHS ENDED 30
JUNE
2024 AMOUNTED TO EUR 140.3 MILLION
    * GALAPAGOS NV - HY OPERATING LOSS 71.3 MILLION EUROS VERSUS
27.7
MILLION EUROS

Source text for Eikon:  ID:nGNE52nWfs 
Further company coverage:  GLPG.AS 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Lakefront Biotherapeutics NV

See all news